302 related articles for article (PubMed ID: 34572686)
1. Antibiotics in Necrotizing Soft Tissue Infections.
Urbina T; Razazi K; Ourghanlian C; Woerther PL; Chosidow O; Lepeule R; de Prost N
Antibiotics (Basel); 2021 Sep; 10(9):. PubMed ID: 34572686
[TBL] [Abstract][Full Text] [Related]
2. [Necrotizing soft tissue infections: role of the localization for the antibiotic management].
Wattel F; Mathieu D; Neut C; Dubreuil L; Cesari JF; Favory R
Bull Acad Natl Med; 2004; 188(3):473-86; discussion 486-90. PubMed ID: 15584657
[TBL] [Abstract][Full Text] [Related]
3. Severe skin infections.
Windsor C; Urbina T; de Prost N
Curr Opin Crit Care; 2023 Oct; 29(5):407-414. PubMed ID: 37641501
[TBL] [Abstract][Full Text] [Related]
4. Essentials in the management of necrotizing soft-tissue infections.
Jung N; Eckmann C
Infection; 2019 Aug; 47(4):677-679. PubMed ID: 31077024
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Necrotizing Soft Tissue Infections: Antibiotics.
Oppegaard O; Rath E
Adv Exp Med Biol; 2020; 1294():87-103. PubMed ID: 33079365
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program.
Ong CT; Kuti JL; Nicolau DP;
Surg Infect (Larchmt); 2005; 6(4):419-26. PubMed ID: 16433606
[TBL] [Abstract][Full Text] [Related]
7. Pathogen identification by shotgun metagenomics of patients with necrotizing soft-tissue infections.
Rodriguez C; Jary A; Hua C; Woerther PL; Bosc R; Desroches M; Sitterlé E; Gricourt G; De Prost N; Pawlotsky JM; Chosidow O; Sbidian E; Decousser JW;
Br J Dermatol; 2020 Jul; 183(1):105-113. PubMed ID: 31610037
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of diabetic foot infections.
Lipsky BA; Berendt AR; Deery HG; Embil JM; Joseph WS; Karchmer AW; LeFrock JL; Lew DP; Mader JT; Norden C; Tan JS;
Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):212S-238S. PubMed ID: 16799390
[TBL] [Abstract][Full Text] [Related]
9. Pediatric necrotizing soft tissue infection after elective surgery: A case report and literature review.
Gheuens L; Roggeman Q; Cortebeeck K; Leyman P; Bernaerts A; De Foer B; Van Leemput J; van Dinther J
Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110195. PubMed ID: 32705989
[TBL] [Abstract][Full Text] [Related]
10. Using clinical pathways to aid in the diagnosis of necrotizing soft tissue infections synthesis of evidence.
Schuster L; Nuñez DE
Worldviews Evid Based Nurs; 2012 Apr; 9(2):88-99. PubMed ID: 22151905
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of studies on extended versus standard infusion of beta-lactam antibiotics.
Chen M; Buurma V; Shah M; Fahim G
Am J Health Syst Pharm; 2019 Sep; 76(18):1383-1394. PubMed ID: 31505562
[TBL] [Abstract][Full Text] [Related]
12. Optimal timing of initial debridement for necrotizing soft tissue infection: A Practice Management Guideline from the Eastern Association for the Surgery of Trauma.
Gelbard RB; Ferrada P; Yeh DD; Williams BH; Loor M; Yon J; Mentzer C; Khwaja K; Khan MA; Kohli A; Bulger EM; Robinson BRH
J Trauma Acute Care Surg; 2018 Jul; 85(1):208-214. PubMed ID: 29485428
[TBL] [Abstract][Full Text] [Related]
13. Necrotizing skin and soft-tissue infections in the intensive care unit.
Peetermans M; de Prost N; Eckmann C; Norrby-Teglund A; Skrede S; De Waele JJ
Clin Microbiol Infect; 2020 Jan; 26(1):8-17. PubMed ID: 31284035
[TBL] [Abstract][Full Text] [Related]
14. Comparing culture and molecular methods for the identification of microorganisms involved in necrotizing soft tissue infections.
Rudkjøbing VB; Thomsen TR; Xu Y; Melton-Kreft R; Ahmed A; Eickhardt S; Bjarnsholt T; Poulsen SS; Nielsen PH; Earl JP; Ehrlich GD; Moser C
BMC Infect Dis; 2016 Nov; 16(1):652. PubMed ID: 27821087
[TBL] [Abstract][Full Text] [Related]
15. Clindamycin Plus Vancomycin Versus Linezolid for Treatment of Necrotizing Soft Tissue Infection.
Dorazio J; Chiappelli AL; Shields RK; Tsai YV; Skinker P; Nabozny MJ; Bauza G; Forsythe R; Rosengart MR; Gunn SR; Marini R; Clarke L; Falcione B; Ludwig J; McCreary EK
Open Forum Infect Dis; 2023 Jun; 10(6):ofad258. PubMed ID: 37351452
[TBL] [Abstract][Full Text] [Related]
16. Massive soft tissue infections: necrotizing fasciitis and purpura fulminans.
Edlich RF; Winters KL; Woodard CR; Britt LD; Long WB
J Long Term Eff Med Implants; 2005; 15(1):57-65. PubMed ID: 15715517
[TBL] [Abstract][Full Text] [Related]
17. Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.
Perry CM; Markham A
Drugs; 1999 May; 57(5):805-43. PubMed ID: 10353303
[TBL] [Abstract][Full Text] [Related]
18. The microbiology of necrotizing soft tissue infections.
Elliott D; Kufera JA; Myers RA
Am J Surg; 2000 May; 179(5):361-6. PubMed ID: 10930480
[TBL] [Abstract][Full Text] [Related]
19. Necrotizing soft tissue infections.
Sarkar B; Napolitano LM
Minerva Chir; 2010 Jun; 65(3):347-62. PubMed ID: 20668422
[TBL] [Abstract][Full Text] [Related]
20. Healthcare trajectory of critically ill patients with necrotizing soft tissue infections: a multicenter retrospective cohort study using the clinical data warehouse of Greater Paris University Hospitals.
Windsor C; Hua C; De Roux Q; Harrois A; Anguel N; Montravers P; Vieillard-Baron A; Mira JP; Urbina T; Gaudry S; Turpin M; Damoisel C; Annane D; Ricard JD; Hersant B; Mekontso Dessap A; Chosidow O; Layese R; de Prost N;
Ann Intensive Care; 2022 Dec; 12(1):115. PubMed ID: 36538244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
